Loading provider…
Loading provider…
Medical Oncology Physician in New York, NY
NPI: 1104246032Primary Employer
Memorial Solid Tumor Group
mskcc.org
HQ Phone
Mobile
Get Evan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2021
NJ State Medical License
2020 - 2025
NY State Medical License
2016 - 2025
NC State Medical License
2021 - 2022

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Memorial Sloan Kettering Cancer Center
Fellowship • Hematology and Medical Oncology
2017 - 2020
New York Presbyterian Hospital (Columbia Campus)
Residency • Internal Medicine
2014 - 2017
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 75 | 220 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 127 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 59 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 11 | 11 |
Authors: Mrinal Gounder, Samuel Singer, Meera Hameed, Sandra Dangelo, Aimee Crago, William Tap, Narasimhan Agaram, Mary Keohan, Cristina Antonescu, Mark Dickson, Naoko Takebe, Joseph Erinjeri, Ping Chi
Journal: Clin Cancer Res
Authors: Ciara Kelly, Martee Hensley, Mrinal Gounder, Sandra Dangelo, Mary Keohan, Cristina Antonescu, Mark Dickson, Ping Chi
Journal: JCO Precis Oncol
Publication Date: 2020-11-06
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Intervention / Treatment: DRUG: Zimberelimab, DRUG: Etrumadenant
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: GlaxoSmithKline
Intervention / Treatment: DRUG: Niraparib